Equities
Health CareMedical Equipment and Services
  • Price (HKD)1.05
  • Today's Change-0.05 / -4.55%
  • Shares traded2.94m
  • 1 Year change-54.35%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Microport Cardioflow Medtech Corp is a China-based investment holding company mainly engaged in the medical device industry. The Company is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The Company's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The Company mainly conducts business within the domestic market.

  • Revenue in HKD (TTM)364.69m
  • Net income in HKD-511.47m
  • Incorporated2019
  • Employees592.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hua Medicine83.10m-229.12m1.69bn177.00--14.27--20.32-0.2344-0.23440.0850.11210.05381.691.98469,479.10-14.84-25.61-17.56-28.8148.78---275.73-1,654.706.06--0.6238--335.31---3.80------
Jacobio Pharmaceuticals Group Co Ltd68.90m-389.53m1.72bn301.00--1.48--24.94-0.5039-0.50390.08921.470.0419--5.21228,901.20-23.66-45.76-26.86-49.305.04---565.36-372.22----0.1636---33.66--3.43--19.18--
Dawnrays Pharmaceutical (Holdings) Ltd1.25bn353.61m1.77bn1.14k5.020.57173.901.420.23530.23530.8312.060.31562.316.371,092,416.008.859.8911.3612.4954.6056.6928.0327.892.2628.890.040535.33-9.903.94-8.951.4163.922.00
Cryofocus Medtech Shanghai Co Ltd44.42m-105.74m2.00bn392.00--11.40--44.95-0.4422-0.44220.18580.7325------113,311.00--------75.83---258.23--4.08--0.0597--50.83--13.13------
SinoMab Bioscience Ltd1.48m-263.70m2.03bn233.00--6.00--1,371.52-0.259-0.2590.00150.30980.0015-------26.20-24.62-32.50-27.7230.92---17,810.33-4,451.74---8.150.604------14.45------
Acotec Scientific Holdings Ltd513.98m15.71m2.16bn638.00132.031.5432.824.210.05230.05231.714.490.31360.72133.44805,605.500.9589--1.03--79.65--3.06--9.122.750.1529--19.80---79.35------
Cutia Therapeutics149.28m-2.13bn2.18bn298.00--1.49--14.64-7.01-7.010.4914.81------500,932.00--------51.60---1,426.91--5.38--0.153--1,110.83---253.30------
Laekna Inc0.00-400.05m2.36bn89.00--2.71-----3.31-3.310.002.24------0.00-------------------5.280.0655------52.81------
Abbisko Cayman Ltd20.67m-468.13m2.41bn258.00--1.12--116.50-0.7233-0.72330.03193.060.0083--1.4080,132.23-18.74---19.67--100.00---2,264.34------0.0177------12.92------
Peijia Medical Ltd478.48m-425.77m2.49bn1.04k--1.01--5.20-0.6269-0.62690.70443.630.14730.77739.51460,080.00-13.11-34.08-14.94-36.9073.7671.62-88.99-448.756.92--0.0886--75.86--3.75------
Frontage Holdings Corp2.03bn84.50m2.59bn1.76k31.060.96467.141.270.04090.04090.98161.320.46360.635.321,154,974.001.914.462.335.2830.1734.004.139.921.394.090.2960.003.7925.61-58.00-0.782640.43--
MicroPort CardioFlow Medtech Corp364.69m-511.47m2.65bn592.00--1.05--7.28-0.2164-0.21640.15431.050.12052.783.67616,026.60-16.91-17.37-18.11-22.962.06-1.67-140.25-180.829.91-11.560.0293--33.94---3.77---14.16--
HighTide Therapeutics Inc0.00-596.30m2.66bn66.00--3.20-----1.26-1.26--1.61------0.00-------------------0.37980.0229-------393.76------
Golden Throat Holdings Group Co Ltd1.04bn271.35m2.75bn869.0010.141.648.772.640.3670.3671.412.280.41814.821.851,199,991.0010.8811.0015.8515.6372.5772.7926.0224.672.4834.740.2182.96-3.096.73-11.0419.61--38.94
CARsgen Therapeutics Holdings Ltd0.00-811.12m3.38bn516.00--1.73-----1.46-1.460.003.390.00----0.00-29.79---32.14----------9.54--0.0452------16.19------
China Isotope & Radiation Corp7.20bn402.38m3.43bn3.11k8.520.67363.150.47651.261.2622.5015.910.53124.221.842,317,837.006.216.5712.8213.2652.4859.8911.7012.621.73--0.191928.277.8215.35-5.432.883.632.92
Data as of May 08 2024. Currency figures normalised to Microport Cardioflow Medtech Corp's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

3.73%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 05 Apr 202450.76m2.10%
Fidelity Management & Research (Hong Kong) Ltd.as of 31 Mar 202413.75m0.57%
Bosera Asset Management Co., Ltd.as of 31 Dec 202210.32m0.43%
Fidelity Management & Research Co. LLCas of 29 Feb 20243.48m0.14%
Degroof Petercam Asset Management SAas of 30 Jun 20223.28m0.14%
BlackRock Advisors (UK) Ltd.as of 02 Apr 20242.66m0.11%
Norges Bank Investment Managementas of 31 Dec 20232.05m0.09%
China Universal Asset Management Co., Ltd.as of 30 Jun 20231.50m0.06%
1832 Asset Management LPas of 29 Feb 20241.14m0.05%
BlackRock Fund Advisorsas of 04 Apr 20241.01m0.04%
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.